CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.
Hotta R, Ohira M, Matsuura T, Muraoka I, Tryphonopoulos P, Fan J, Tekin A, Selvaggi G, Levi D, Ruiz P, Ricordi C, Vianna R, Ohdan H, Waldmann H, Tzakis AG, Nishida S.
Hotta R, et al. Among authors: vianna r.
PLoS One. 2016 Aug 25;11(8):e0161618. doi: 10.1371/journal.pone.0161618. eCollection 2016.
PLoS One. 2016.
PMID: 27560943
Free PMC article.